首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   12386篇
  免费   1012篇
  国内免费   265篇
耳鼻咽喉   132篇
儿科学   313篇
妇产科学   422篇
基础医学   1583篇
口腔科学   375篇
临床医学   1390篇
内科学   2324篇
皮肤病学   194篇
神经病学   742篇
特种医学   431篇
外国民族医学   1篇
外科学   1637篇
综合类   848篇
现状与发展   3篇
一般理论   3篇
预防医学   716篇
眼科学   302篇
药学   1112篇
  1篇
中国医学   393篇
肿瘤学   741篇
  2023年   136篇
  2022年   193篇
  2021年   406篇
  2020年   252篇
  2019年   350篇
  2018年   424篇
  2017年   300篇
  2016年   314篇
  2015年   419篇
  2014年   531篇
  2013年   619篇
  2012年   948篇
  2011年   925篇
  2010年   523篇
  2009年   449篇
  2008年   675篇
  2007年   659篇
  2006年   639篇
  2005年   613篇
  2004年   480篇
  2003年   437篇
  2002年   365篇
  2001年   336篇
  2000年   366篇
  1999年   277篇
  1998年   115篇
  1997年   129篇
  1996年   92篇
  1995年   82篇
  1994年   66篇
  1993年   72篇
  1992年   197篇
  1991年   162篇
  1990年   141篇
  1989年   119篇
  1988年   113篇
  1987年   98篇
  1986年   80篇
  1985年   81篇
  1984年   58篇
  1983年   35篇
  1982年   25篇
  1979年   33篇
  1978年   31篇
  1977年   31篇
  1974年   26篇
  1973年   27篇
  1971年   21篇
  1970年   24篇
  1968年   21篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Lessons Learned
  • SCB01A is a novel microtubule inhibitor with vascular disrupting activity.
  • This first‐in‐human study demonstrated SCB01A safety, pharmacokinetics, and preliminary antitumor activity.
  • SCB01A is safe and well tolerated in patients with advanced solid malignancies with manageable neurotoxicity.
BackgroundSCB01A, a novel microtubule inhibitor, has vascular disrupting activity.MethodsIn this phase I dose‐escalation and extension study, patients with advanced solid tumors were administered intravenous SCB01A infusions for 3 hours once every 21 days. Rapid titration and a 3 + 3 design escalated the dose from 2 mg/m2 to the maximum tolerated dose (MTD) based on dose‐limiting toxicity (DLT). SCB01A‐induced cellular neurotoxicity was evaluated in dorsal root ganglion cells. The primary endpoint was MTD. Safety, pharmacokinetics (PK), and tumor response were secondary endpoints.ResultsTreatment‐related adverse events included anemia, nausea, vomiting, fatigue, fever, and peripheral sensorimotor neuropathy. DLTs included grade 4 elevated creatine phosphokinase (CPK) in the 4 mg/m2 cohort; grade 3 gastric hemorrhage in the 6.5 mg/m2 cohort; grade 2 thromboembolic event in the 24 mg/m2 cohort; and grade 3 peripheral sensorimotor neuropathy, grade 3 elevated aspartate aminotransferase, and grade 3 hypertension in the 32 mg/m2 cohort. The MTD was 24 mg/m2, and average half‐life was ~2.5 hours. The area under the curve‐dose response relationship was linear. Nineteen subjects were stable after two cycles. The longest treatment lasted 24 cycles. SCB01A‐induced neurotoxicity was reversible in vitro.ConclusionThe MTD of SCB01A was 24 mg/m2 every 21 days; it is safe and tolerable in patients with solid tumors.  相似文献   
2.
3.
4.
In the present review, we updated current information on the chemistry, contents, and anticancer properties of matrine (MT), oxymatrine (OMT), and compound Kushen injection (CKI). The anticancer properties were focused on lung, breast, and liver cancer cells because they are most susceptible. Sources of information were from Google, Google Scholar, PubMed, PubMed Central, Science Direct, PubChem, J-Stage, Directory of Open Access Journals (DOAJ), and China National Knowledge Infrastructure (CNKI). Reference was also made on botanical websites, such as Flora of China and World Flora Online. MT and OMT are dominant quinolizidine alkaloids from the roots of Sophora flavescens (Kushen) of the family Fabaceae. Against lung, breast, and liver cancer cells, MT and OMT inhibit cell proliferation; induce cell cycle arrest, apoptosis, and autophagy; restrict angiogenesis; and inhibit cell metastasis, invasion, and migration. The processes involve various molecular targets and signaling pathways. CKI is a traditional Chinese medicine (TCM) composed of root extracts of S. flavescens and Smilax glabra (Baituling) of the family Smilacaceae. With MT and OMT as major components, CKI has been approved for the treatment of cancer in China more than 20 years ago. In recent years, systematic reviews and meta-analysis have been undertaken to evaluate the anticancer effects of CKI. When CKI is used alone and in combination with chemotherapy of western medicine, there is much to be learned concerning their interactions besides their individual and integrated efficacy. Some perspectives of MT, OMT, and CKI are discussed, and their suggestions for future research are provided.  相似文献   
5.

Introduction

For never-smokers (smoked <100 lifetime cigarettes), lung cancer (LC) has emerged as an important issue. We aimed to investigate the effects of prevalence changes in tobacco smoking and particulate matter (PM) 2.5 (PM2.5) levels on LC in Taiwan, in relation to contrasting PM2.5 levels, between Northern Taiwan (NT) and Southern Taiwan (ST).

Methods

We reviewed 371,084 patients with LC to assess smoking prevalence and correlations between the incidence of adenocarcinoma lung cancer (AdLC) and non-AdLC. Two subsets were selected to assess different AdLC stage trends and the effect of PM2.5 on survival of patients with AdLC.

Results

From 1995 to 2015, the proportion of male adult ever-smokers decreased from 59.4% to 29.9% whereas the female smoking rate remained low (3.2% to 5.3%). AdLC incidence in males and females increased from 9.06 to 23.25 and 7.05 to 24.22 per 100,000 population, respectively. Since 1993, atmospheric visibility in NT improved (from 7.6 to 11.5 km), but deteriorated in ST (from 16.3 to 4.2 km). The annual percent change in AdLC stages IB to IV was 0.3% since 2009 (95% confidence interval [CI]: -1.9%–2.6%) in NT, and 4.6% since 2007 (95% CI: 3.3%–5.8%) in ST; 53% patients with LC had never smoked. Five-year survival rates for never-smokers, those with EGFR wild-type genes, and female patients with AdLC were 12.6% in NT and 4.5% in ST (hazard ratio: 0.79, 95% CI: 0.70–0.90).

Conclusions

In Taiwan, greater than 50% of patients with LC had never smoked. PM2.5 level changes can affect AdLC incidence and patient survival.  相似文献   
6.
7.
8.
VAGAL paraganglioma VP)is an uncommonneoplasm originating from neural crest paragan-glion cells located along the vagus nerve,repre-senting less than5%of all paragangliomas of the head andneck.1Despite improvement in microsurgical techniques,management of…  相似文献   
9.
目的:讨论萘对人体的慢性毒效应和亚临床客观检测指标。方法:对河南省萘暴露工人(环境接触萘浓度平均为8.25~26.43mg/m3)进行了健康监护和医学动态观察。结果:发现长期萘暴露工人的白细胞、血小板减少及眼晶体混浊检出率显著高于对照组(P<0.001);血清SOD同功酶、GSH-PX活性显著低于对照组,而LPO水平、神经元特异性烯醇化酶(NSE)活性水平以及外周血染色体畸变和微核阳性检出率均显著高于对照组(P<0.001)。神经行为功能检查结果,主要为消极情绪增加,记忆力下降等。事件相关电位P300峰潜伏期比对照组显著延长,与对照组差异显著(P<0.05)。结论:慢性低浓度萘暴露对工人主要损害部位(靶器官)有皮肤,眼、血液和神经组织等。NCTB、NSE、P300三项可作为早期神经受损的客观指标。  相似文献   
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号